Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Bachmann

Showing results (21-30 of 250) with videos related to

Pageof 25
Sort By:
Biological Chemistry|October 28, 2008
The coming of age of virus-like particle vaccinesGary T Jennings, Martin F Bachmann
Vaccines|July 26, 2020
COVID-19: Mechanisms of Vaccination and ImmunityDaniel E Speiser, Martin F Bachmann
Nature Reviews. Drug Discovery|December 11, 2003
Therapeutic vaccination for chronic diseases: a new class of drugs in sightMartin F Bachmann, Mark R Dyer
Current Molecular Medicine|March 10, 2007
Designing recombinant vaccines with viral properties: a rational approach to more effective vaccinesGary T Jennings, Martin F Bachmann
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2022
Linking Viral DNA to Endosomal Innate Immune RecognitionMartin F Bachmann, Daniel E Speiser
Drug Discovery Today|January 28, 2003
Immunotherapies: cause for measured optimismGary T Jennings, Martin F Bachmann
Cellular & Molecular Immunology|August 12, 2022
Virus-like particle vaccinology, from bench to bedsideMona O Mohsen, Martin F Bachmann
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 7, 2011
Therapeutic vaccines for chronic diseases: successes and technical challengesMartin F Bachmann, Gary T Jennings
Nature Reviews. Immunology|October 16, 2010
Vaccine delivery: a matter of size, geometry, kinetics and molecular patternsMartin F Bachmann, Gary T Jennings
Annual Review of Pharmacology and Toxicology|October 15, 2008
Immunodrugs: therapeutic VLP-based vaccines for chronic diseasesGary T Jennings, Martin F Bachmann
Pageof 25

Showing results (21-30 of 250) with videos related to

Sort By:
Pageof 25
Biological Chemistry|October 28, 2008
The coming of age of virus-like particle vaccinesGary T Jennings, Martin F Bachmann
Vaccines|July 26, 2020
COVID-19: Mechanisms of Vaccination and ImmunityDaniel E Speiser, Martin F Bachmann
Nature Reviews. Drug Discovery|December 11, 2003
Therapeutic vaccination for chronic diseases: a new class of drugs in sightMartin F Bachmann, Mark R Dyer
Current Molecular Medicine|March 10, 2007
Designing recombinant vaccines with viral properties: a rational approach to more effective vaccinesGary T Jennings, Martin F Bachmann
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2022
Linking Viral DNA to Endosomal Innate Immune RecognitionMartin F Bachmann, Daniel E Speiser
Drug Discovery Today|January 28, 2003
Immunotherapies: cause for measured optimismGary T Jennings, Martin F Bachmann
Cellular & Molecular Immunology|August 12, 2022
Virus-like particle vaccinology, from bench to bedsideMona O Mohsen, Martin F Bachmann
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 7, 2011
Therapeutic vaccines for chronic diseases: successes and technical challengesMartin F Bachmann, Gary T Jennings
Nature Reviews. Immunology|October 16, 2010
Vaccine delivery: a matter of size, geometry, kinetics and molecular patternsMartin F Bachmann, Gary T Jennings
Annual Review of Pharmacology and Toxicology|October 15, 2008
Immunodrugs: therapeutic VLP-based vaccines for chronic diseasesGary T Jennings, Martin F Bachmann
Pageof 25